Anti-infective discovery is evolving with AI and robotics – learn how UK researchers aim to cut development time and improve ...

Welcome to the second installment of "Cancer and the Gut Microbiome: A Miniseries". Here, we focus on how the microbiome ...

The Technology Networks team attended ASMS 2025 and spoke with Jim Gearing, who discusses the challenges that contaminant analysts face, and how Agilent are addressing these challenges by developing ...

At ASMS 2025, the Technology Networks team caught up with Jim Gearing, Associate Vice President of Marketing, Gas Phase ...

We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, ...

A new study shows that patients achieve good outcomes with a partial match drawn from the national public registry of donors ...

Researchers have discovered a potential treatment target that may re-energize dysfunctional or “exhausted” immune cells in ...

Researchers were able to prove for the first time that monocytes, important immune cells in the blood, react more strongly to ...

Researchers from Mass General Brigham discovered that HBV does not cause liver inflammation or cancer on its own, but worsens ...

A portable diagnostic device that uses a beetle-inspired chemical reaction has shown improved detection of tuberculosis in ...

Deconstructing epoxy resins with hot acetic acid has the potential to provide a scalable and affordable solution for ...

Researchers at the University of Cologne have identified the key mitochondrial protein AIFM1 as a central coordinator of ...